BCL-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress

Girija Dasmahapatra, Dmitry Lembersky, Mohamed Rahmani, Lora Kramer, Jonathan Friedberg, Richard I. Fisher, Paul Dent, Steven Grant

Open source

DOI: 10.4161/cbt.8.9.8131
Published: 2009-05
Container: Cancer Biology & Therapy
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
cautionRetraction Watch correction: 1 correction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4161/cbt.8.9.8131,
  title = {BCL-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress},
  author = {Girija Dasmahapatra and Dmitry Lembersky and Mohamed Rahmani and Lora Kramer and Jonathan Friedberg and Richard I. Fisher and Paul Dent and Steven Grant},
  year = {2009},
  journal = {Cancer Biology \&amp; Therapy},
  doi = {10.4161/cbt.8.9.8131},
  url = {https://doi.org/10.4161/cbt.8.9.8131}
}

RIS

TY  - JOUR
TI  - BCL-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress
AU  - Girija Dasmahapatra
AU  - Dmitry Lembersky
AU  - Mohamed Rahmani
AU  - Lora Kramer
AU  - Jonathan Friedberg
AU  - Richard I. Fisher
AU  - Paul Dent
AU  - Steven Grant
PY  - 2009
JO  - Cancer Biology &amp; Therapy
DO  - 10.4161/cbt.8.9.8131
UR  - https://doi.org/10.4161/cbt.8.9.8131
ER  -

APA

Dasmahapatra, G., Lembersky, D., Rahmani, M., Kramer, L., Friedberg, J., Fisher, R. I., Dent, P., & Grant, S. (2009). BCL-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress. Cancer Biology & Therapy. https://doi.org/10.4161/cbt.8.9.8131

Source records

crossref · retrieved 2026-09-25T03:56:19.607Z